Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2012
03/22/2012CA2811403A1 Bioproduction of aromatic chemicals from lignin-derived compounds
03/22/2012CA2811295A1 Broad spectrum antibiotic arylomycin analogs
03/22/2012CA2811206A1 Thermophilic mutants of trichoderma reesei endoglucanase i
03/22/2012CA2811182A1 Target genes for control of plant parasitic nematodes and use of same
03/22/2012CA2811103A1 Computationally optimized broadly reactive antigens for influenza
03/22/2012CA2810812A1 Method for producing lilies containing delphinidin in the petals thereof
03/22/2012CA2808675A1 Serpin-finger fusion polypeptide
03/21/2012EP2431480A2 Methods and compositions for increasing the stress resistance of cells and organisms
03/21/2012EP2431478A1 Methods and compositions for expressing negative-sense viral RNA in canine cells
03/21/2012EP2431476A1 Coryneform bacteria with glycine cleavage activity
03/21/2012EP2431474A1 Screening tool for antiviral agents
03/21/2012EP2431473A1 Methods for genetic control of insect infestations in plants and compositions thereof
03/21/2012EP2431472A1 Plant yield improvement by STE20-like gene expression
03/21/2012EP2431471A1 Methods for increasing the size of plants or plant organs
03/21/2012EP2431470A1 DNase expression in recombinant host cells
03/21/2012EP2431469A2 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
03/21/2012EP2431468A1 Interleukin-1 conjugates and uses thereof
03/21/2012EP2431467A2 Modulation of gene expression by oligomers targeted to chromosomal DNA
03/21/2012EP2431466A1 Single-strand nucleic acid molecule for controlling gene expression
03/21/2012EP2431465A1 Method for synthesis of double-stranded dna corresponding to rna, and method for amplification of the dna
03/21/2012EP2431464A1 Aptamer that recognizes peptide
03/21/2012EP2431463A1 Test agent for visceral obesity and use thereof
03/21/2012EP2431462A2 Novel endoglucanases
03/21/2012EP2431459A1 Components of cell culture media produced from plant cells
03/21/2012EP2431458A1 Components of cell culture media produced from plant cells
03/21/2012EP2431405A1 Fine particles of crystalline polyol and method of preparing same
03/21/2012EP2431390A1 Compositions and methods for modulating hemostasis
03/21/2012EP2431389A1 Compositions and methods for modulating hemostasis
03/21/2012EP2431387A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/21/2012EP2431386A1 Na+/Mg2+ exchanger
03/21/2012EP2431378A2 Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method
03/21/2012EP2431055A1 Conjugates of membrane translocating agents and pharmaceutically active agents
03/21/2012EP2430923A1 Compositions and methods for liver growth and liver protection
03/21/2012EP2430449A1 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
03/21/2012EP2430191A1 Phosphodiesterase 4d7 as prostate cancer marker
03/21/2012EP2430190A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer
03/21/2012EP2430189A1 Phosphodiesterase 9a as prostate cancer marker
03/21/2012EP2430180A1 Gene synthesis method
03/21/2012EP2430168A1 Compositions comprising cationic amphiphiles and colipids for delivering therapeutics molecules
03/21/2012EP2430167A1 Aslv vector system
03/21/2012EP2430166A1 Acyltransferases and uses thereof in fatty acid production
03/21/2012EP2430165A1 Combinatorial engineering
03/21/2012EP2430164A2 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
03/21/2012EP2430163A1 Method for producing a protein of interest using a novel fusion protein
03/21/2012EP2430162A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
03/21/2012EP2430161A1 Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
03/21/2012EP2430160A1 Plant promoter operable in basal endosperm transfer layer of endosperm and uses thereof
03/21/2012EP2430159A1 Improved cell lines having reduced expression of nocr and use thereof
03/21/2012EP2430158A1 Nucleic acid purification method
03/21/2012EP2430156A1 Modified fluorescent proteins and methods for using same
03/21/2012EP2430151A2 Menigococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
03/21/2012EP2430150A1 Recombinant bacteria and the uses thereof for producing ethanol
03/21/2012EP2430050A1 Humanized axl antibodies
03/21/2012EP2430039A1 Ttk peptides and vaccines including the same
03/21/2012EP2430038A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
03/21/2012EP2429565A2 Peptides and aptamers for targeting of neuron or nerves
03/21/2012EP2410058A9 Modification of flavonoid biosynthesis in plants with transparent testa 2
03/21/2012EP2296669B1 Targeted oligonucleotide compositions for modifying gene expression
03/21/2012EP2209898B8 Two step cluster deletion and humanisation
03/21/2012EP2185710B1 Eukaryotic promoters for gene expression
03/21/2012EP2152732B1 A modified secretion system to increase expression of polypeptides in bacteria
03/21/2012EP2074147B1 Antibodies against ccr5 and uses thereof
03/21/2012EP1966244B1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
03/21/2012EP1941042B1 A novel hansenula polymorpha gene coding for dolichyl-phosphate-mannose dependent alpha-1,3-mannosyltransferase and process for the production of recombinant glycoproteins with hansenula polymorpha mutant strain deficient in the same gene
03/21/2012EP1934345B1 Modification of rna, producing an increased transcript stability and translation efficiency
03/21/2012EP1824977B1 Promoter nucleic acid derived from Corynebacterium genus , expression cassette comprising the promoter and vector , host cell comprising the vector , vector and method for expressing a gene using the cell .
03/21/2012EP1815014B1 Molecular indicators of breast cancer prognosis and prediction of treatment response
03/21/2012EP1809750B1 Selection of host cells expressing protein at high levels
03/21/2012EP1688488B9 Bispecific antibody substituting for factor viii
03/21/2012EP1685244B1 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates
03/21/2012EP1668137B8 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
03/21/2012EP1664321B1 Methods for expression and purification of immunotoxins
03/21/2012EP1650302B1 Protein capable of deposition onto extracellular matrix
03/21/2012EP1532142B1 Polypeptide cleavage process
03/21/2012EP1515988B1 Dna sequence and recombinant production of the grass pollen allergen phl p4
03/21/2012EP1506409B1 Assays for modulators of asparaginyl hydroxylase
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012EP1391507B1 Apparatus for purifying nucleic acid and method of purifying nucleic acid
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012EP1313853B1 Modulation of fas and fasl expression by a synthetic phosphodiester oligonucleotide and an anti-fas antibody
03/21/2012EP1088077B2 Newcastle disease virus infectious clones, vaccines and diagnostic assays
03/21/2012CN1974758B Culture method engineering bacterium capable of producing 5-amino acetyl propionic acid in high yield
03/21/2012CN1966690B Prokaryotic expression plasmid vector pKpL5 for use in genetic engineering production an its construction
03/21/2012CN1946430B Therapeutic agent for treatment of cancer comprising human apolipoprotein (A) kringles LK68 or LK8 genes as effective ingredient, and method for treating cancer using the same
03/21/2012CN1860110B Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol
03/21/2012CN1845990B Method of making sucrose phosphorylase (SP) heat-stable
03/21/2012CN1756843B Streptococcus pyogenes antigens
03/21/2012CN1717489B Sequence specific DNA recombination in eukaryotic cells
03/21/2012CN1554764B Recombinant mva virus, and the use thereof
03/21/2012CN102388148A Apparatus for integrated real-time nucleic acid analysis, and method for detecting a target nucleic acid using same
03/21/2012CN102388143A Axmi-150 delta-endotoxin gene and methods for its use
03/21/2012CN102388142A Use of at(n) insertions in promoter elements for controlling the expression levels of coding sequences in plants
03/21/2012CN102388141A Production method for 1,3-propanediol using recombinant microbial strain having glycerol oxidation metabolic pathway blocked
03/21/2012CN102388140A Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor
03/21/2012CN102388139A Modulation of toll-like receptor 5 expression by antisense oligonucleotides
03/21/2012CN102388138A Spatially inhomogenously functionalized porous media and method for use in selective removal of contaminants
03/21/2012CN102388137A Novel lysophospholipid acyltransferase
03/21/2012CN102388136A Novel nuclear reprogramming substance
03/21/2012CN102388135A Protease for wound conditioning and skin care
03/21/2012CN102388134A Polypeptides having beta-glucosidase activity and polynucleotides encoding same